Global
CN
EN
HOME
ABOUT US
About Laekna
Core Management Team
Board of Directors
Milestones
Scientific Advisory Board
Core Investors
Honors & Awards
R&D
R&D
Therapeutic Areas
Candidates
Pipeline
Clinical Trials
PARTNERSHIPS
Strategic Partners
Business Development
Holistic Approach
BD Contact
INVESTORS
Corporate Governance
Financial Results
Announcements and Circulars
IR Calendar
Listing Documents
NEWS
Press Releases
Media Coverage
CAREERS
Global Team
Career Development
Jobs
My Laekna
CONTACT US
Contact Us
Leave Message
RSS Feeds
INVESTOR RELATIONS
CURE FOR A BETTER FUTURE
Scroll down to see more
Announcements and Circulars
2025
2024
2023
June 30, 2025
[Announcements and Notices]
- VOLUNTARY ANNOUNCEMENT SUBMISSION OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE103 TO THE U.S. FOOD AND DRUG ADMINISTRATION
More
June 23, 2025
[Announcements and Notices]
- VOLUNTARY ANNOUNCEMENT PRESENTATIONS OF CLINICAL AND PRECLINICAL STUDIES RESULTS OF LAE102, LAE103 AND LAE123 AT 2025 ADA
More
June 05, 2025
[Monthly Returns]
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
More
June 04, 2025
[Announcements and Notices]
- POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 3 JUNE 2025
More
May 12, 2025
[Proxy Forms]
- PROXY FORM FOR THE ANNUAL GENERAL MEETING
More
May 12, 2025
[Announcements and Notices]
- NOTICE OF ANNUAL GENERAL MEETING
More
<
1
2
3
4
>
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
Name
*
Email
*
Company
Occupation
News
Positions
Follow us on Linkedin
HOME
ABOUT US
R&D
PARTNERSHIPS
INVESTORS
NEWS
CAREERS
CONTACT US
PRIVACY POLICY
占位
Global
—English
|
中国
—简体中文
